Petros Pharmaceuticals, Inc.
Ticker: 1815903
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY24 | Q2 FY24 | Q1 FY24 | Q2 FY23 | Q1 FY23 | Q2 FY22 | Q1 FY22 | Q3 FY21 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.58+11.3% | 1.42+2.2% | 1.39-30.2% | 1.99-21.0% | 2.52-39.9% | 4.19+69.6% | 2.47+14.9% | 2.15 |
| Total Income | 1.58+11.3% | 1.42+2.2% | 1.39-30.2% | 1.99-21.0% | 2.52-39.9% | 4.19+69.6% | 2.47+14.9% | 2.15 |
| EXPENSES | ||||||||
| Expenditure | 3.92+5.9% | 3.70-30.5% | 5.32+19.3% | 4.46+16.4% | 3.83-34.5% | 5.85+98.3% | 2.95-48.6% | 5.74 |
| Tax | — | — | — | — | — | — | — | 0.00 |
| PROFIT | ||||||||
| PBT | -2.22-236.4% | -0.66+69.4% | -2.16 | — | — | -1.81 | — | -1.69 |
| Net Profit | -2.22-236.4% | -0.66+69.4% | -2.16+15.3% | -2.55-83.5% | -1.39+23.2% | -1.81-964.7% | -0.17+90.0% | -1.70 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00%-48.00pp | -52.00%-12.31pp | -39.69%-20.17pp | -19.52%+80.48pp | -100.00% |
| NPM % | -100.00%-53.43pp | -46.57%+53.43pp | -100.00% | -100.00%-44.99pp | -55.01%-11.73pp | -43.28%-36.21pp | -7.07%+72.04pp | -79.10% |
| EPS | -0.53-43.2% | -0.37+78.1% | -1.69-40.8% | -1.20-81.8% | -0.66-633.3% | -0.09-800.0% | -0.01+94.1% | -0.17 |
Corporate Events
Board MeetingPTPI
202618Jun
Board Meeting
CFO Transition - Mitchell Arnold's mutual separation and Rob…
SEC Filing ↗ Board MeetingPTPI
20265Jun
Board Meeting
Board approved grants of restricted shares to Chairman Joshu…
SEC Filing ↗